IRCT20220211053993N1尚未招募3 期
Evaluation of the Effect of Methylene Blue with Supplements in the Treatment of Patients with Moderate to Severe Outpatient COVID-19 Infection in Comparison with the Control Group
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Outpatients with COVID-19 virus referred to a Lung Clinic Confirmed by HRCT or PCR
- •SPO2 without Mask after Ten Minutes between 70-96
- •Age Over 18 Years Old
排除标准
- •Severe Liver and Heart Disease
- •Acute Renal Failure Associated with the Need for Dialysis
- •Glucose 6-Phosphate Dehydrogenase Deficiency
研究者
相似试验
尚未招募
3 期
Comparison of two different medicines named Methylene Blue and Vasopressin for increasing blood pressure in patients with infection and low blood pressureCTRI/2023/06/053979AIIMS New Delhi
已完成
不适用
Determining the effect of methylene blue on postoperative pain and quality of life after lumbar laminectomy and discectomyPostoperative pain improvement..IRCT138807142193N4Shiraz University of Medical Sciences130
招募中
4 期
Investigation of Methylene Blue for treatment of COVID-19 outpatients referred to pulmonary clinic.COVID-19.U07.1COVID-19,IRCT20191228045924N2Mashhad University of Medical Sciences240
尚未招募
3 期
Study of injection methylene blue after surgery around anus for decreasing paiCTRI/2023/09/057852Dr Pratik Jadhav
进行中（未招募）
不适用
Staining efficacy and safety of Methylene Blue enemas in patients undergoing rectum and sigma examination for various reasonsOut-patients of both sexes with indication for diagnostic flexible rectosigmoidoscopy.MedDRA version: 14.1Level: LLTClassification code 10016774Term: Flexible sigmoidoscopySystem Organ Class: 100000004848EUCTR2013-000452-18-ITCosmo Technologies Ltd.